Stewart & Patten CO LLC Eli Lilly & CO Transaction History

Stewart & Patten CO LLC

$664 Million
Q1 2024

A detailed history of Stewart & Patten CO LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Stewart & Patten CO LLC holds 1,330 shares of LLY stock, worth $1.21 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,330

Previous 1,560 14.74%

Holding current value

$1.21 Million

Previous $909,000 13.75%

% of portfolio

0.16%

Previous 0.14%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	SELL	$592.2 - $792.28 $136,206 - $182,224	-230 Reduced 14.74%	1,330 $1.03 Million
Q4 2023 Jan 18, 2024	SELL	$525.19 - $619.13 $52,519 - $61,913	-100 Reduced 6.02%	1,560 $909,000
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $192,907 - $257,939	-550 Reduced 24.89%	1,660 $778,000
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $40,381 - $47,426	-130 Reduced 5.56%	2,210 $758,000
Q4 2022 Jan 30, 2023	SELL	$321.55 - $374.67 $32,155 - $37,467	-100 Reduced 4.1%	2,340 $856,000
Q3 2022 Oct 19, 2022	SELL	$296.48 - $337.87 $57,813 - $65,884	-195 Reduced 7.4%	2,440 $789,000
Q2 2022 Jul 21, 2022	SELL	$278.73 - $327.27 $56,303 - $66,108	-202 Reduced 7.12%	2,635 $854,000
Q1 2022 Apr 22, 2022	SELL	$234.69 - $291.66 $139,171 - $172,954	-593 Reduced 17.29%	2,837 $812,000
Q3 2021 Oct 20, 2021	SELL	$221.6 - $272.71 $46,536 - $57,269	-210 Reduced 5.77%	3,430 $793,000
Q1 2021 Apr 21, 2021	SELL	$164.32 - $212.72 $30,399 - $39,353	-185 Reduced 4.84%	3,640 $680,000
Q4 2020 Jan 25, 2021	SELL	$130.46 - $172.63 $234,828 - $310,734	-1,800 Reduced 32.0%	3,825 $646,000
Q3 2020 Oct 22, 2020	SELL	$146.22 - $169.13 $80,421 - $93,021	-550 Reduced 8.91%	5,625 $833,000
Q2 2020 Jul 17, 2020	SELL	$136.42 - $164.18 $77,077 - $92,761	-565 Reduced 8.38%	6,175 $1.01 Million
Q1 2020 Apr 16, 2020	SELL	$119.05 - $147.35 $85,239 - $105,502	-716 Reduced 9.6%	6,740 $935,000
Q3 2019 Oct 17, 2019	SELL	$106.79 - $116.16 $21,358 - $23,232	-200 Reduced 2.61%	7,456 $834,000
Q2 2019 Jul 17, 2019	SELL	$110.79 - $129.32 $20,606 - $24,053	-186 Reduced 2.37%	7,656 $848,000
Q1 2019 Apr 18, 2019	SELL	$111.31 - $131.02 $9,906 - $11,660	-89 Reduced 1.12%	7,842 $1.02 Million
Q4 2018 Jan 17, 2019	SELL	$105.9 - $118.64 $105,900 - $118,640	-1,000 Reduced 11.2%	7,931 $918,000
Q3 2018 Oct 22, 2018	SELL	$85.86 - $107.31 $128,790 - $160,965	-1,500 Reduced 14.38%	8,931 $958,000
Q2 2018 Jul 25, 2018	SELL	$75.7 - $86.88 $22,710 - $26,064	-300 Reduced 2.8%	10,431 $890,000
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $14,841 - $17,520	-200 Reduced 1.83%	10,731 $830,000
Q4 2017 Jan 29, 2018	SELL	$81.94 - $87.89 $24,582 - $26,367	-300 Reduced 2.67%	10,931 $923,000
Q3 2017 Oct 27, 2017	BUY	$77.07 - $85.54 $865,573 - $960,699	11,231	11,231 $961,000

Others Institutions Holding LLY

# of Institutions

3,865

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $867B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stewart & Patten CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stewart & Patten CO LLC with notifications on news.

Account

Stewart & Patten CO LLC Eli Lilly & CO Transaction History